Department of Medicine, University of Otago Wellington, PO Box 7343, Wellington 6012, New Zealand; Centre of Endocrine, Diabetes and Obesity Research (CEDOR) Wellington, Level 5, Grace Neill Block, Wellington Regional Hospital, Riddiford St, Newtown, Wellington, New Zealand.
Department of Medicine, University of Otago Wellington, PO Box 7343, Wellington 6012, New Zealand; Centre of Endocrine, Diabetes and Obesity Research (CEDOR) Wellington, Level 5, Grace Neill Block, Wellington Regional Hospital, Riddiford St, Newtown, Wellington, New Zealand.
J Diabetes Complications. 2024 Jul;38(7):108778. doi: 10.1016/j.jdiacomp.2024.108778. Epub 2024 May 27.
Postprandial hyperglycemia can be problematic for people with type 1 diabetes (T1DM) following carbohydrate-restricted diets. Bolus insulin calculated for meal protein plus carbohydrate may help. This study evaluated the effect of additional bolus insulin using an insulin-to-protein ratio (IPR) on glycaemic control.
Participants with T1DM aged ≥18-years were randomly allocated (1:1) to either carbohydrate and protein-based, or carbohydrate-based insulin dosing alone for 12 weeks while following a carbohydrate-restricted diet (50-100 g/day). Measurement of HbA1c and continuous glucose monitoring occurred at baseline and 12 weeks, with assessment of participant experience at 12 weeks.
Thirty-four participants were randomised, 22 female, mean(SD): age 39.2 years (12.6) years; diabetes duration 20.6 years (12.9); HbA1c 7.3 % (0.8), 56.7 mmol/mol (9.2). Seven in each group used insulin pump therapy. HbA1c reduced at 12 weeks with no difference between treatments: mean (SD) control 7.2 % (1.0), 55.7 mmol/mol (10.6); intervention 6.9 % (0.7), 52.3 mmol/mol (7.2) (p = 0.65). Using additional protein-based insulin dosing compared with carbohydrate alone, there was no difference in glycaemic variability, time spent in euglycemic range (TIR), or below range. Participants using IPR reported more control of their diabetes, but varying levels of distress.
Additional bolus insulin using an IPR did not improve glycaemic control or TIR in patients with well controlled T1DM following a carbohydrate-restricted diet. Importantly, the use of the IPR does not increase the risk of hypoglycemia and may be preferred.
对于接受低碳水化合物饮食的 1 型糖尿病(T1DM)患者,餐后高血糖可能是一个问题。计算用于餐食蛋白质加碳水化合物的餐时胰岛素可能会有所帮助。本研究评估了使用胰岛素与蛋白质比值(IPR)额外给予餐时胰岛素对血糖控制的影响。
年龄≥18 岁的 T1DM 参与者被随机分配(1:1)接受基于碳水化合物和蛋白质或仅基于碳水化合物的胰岛素剂量治疗,持续 12 周,同时遵循低碳水化合物饮食(50-100g/天)。在基线和 12 周时测量糖化血红蛋白(HbA1c)和连续血糖监测,并在 12 周时评估参与者的体验。
34 名参与者被随机分配,22 名女性,平均(SD)年龄 39.2 岁(12.6)岁;糖尿病病程 20.6 年(12.9);HbA1c 7.3%(0.8),56.7mmol/mol(9.2)。每组各有 7 人使用胰岛素泵治疗。12 周时 HbA1c 降低,两种治疗方法之间无差异:对照组平均(SD)为 7.2%(1.0),55.7mmol/mol(10.6);干预组为 6.9%(0.7),52.3mmol/mol(7.2)(p=0.65)。与单独使用碳水化合物相比,使用基于蛋白质的额外胰岛素剂量,血糖变异性、血糖达标时间(TIR)或血糖低于目标范围的时间没有差异。使用 IPR 的参与者报告对糖尿病的控制更好,但存在不同程度的困扰。
对于接受低碳水化合物饮食、血糖控制良好的 T1DM 患者,使用 IPR 给予额外的餐时胰岛素并不能改善血糖控制或 TIR。重要的是,使用 IPR 不会增加低血糖的风险,并且可能是首选。